Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer

PHASE1/PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 30, 2024

Conditions
Diabetic Foot Ulcer
Interventions
DRUG

Allogeneic mesenchymal stem cells (MSCs)

Dosage · Dosing of IMP is based on ulcer size. The recommended dose is 1 million cells/cm2 of ulcer. Administration · Injections will be done through peri-ulcer route. · Injection will be done 0.75 cm from the edge of the ulcer. · Injection will be done using 24G. The volume of injection will 4.0 - 6.0 ml per patient (maximum 0.1 to 0.2 ml per injection; 30 injections maximum per patients)

DRUG

Normal Saline

Dosage · Dosing of placebo is based on ulcer size. the volume will be samed as the experimental groups which is 2 ml per 1cm2 Administration · Injections will be done through peri-ulcer route. · Injection will be done 0.75 cm from the edge of the ulcer. · Injection will be done using 24G. The volume of injection will 4.0 - 6.0 ml per patient (maximum 0.1 to 0.2 ml per injection; 30 injections maximum per patients)

All Listed Sponsors
lead

Supergenics Life Science Sdn. Bhd.

INDUSTRY

NCT06231771 - Safety and Efficacy of Stem Cells for Diabetic Foot Ulcer | Biotech Hunter | Biotech Hunter